These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4585972)

  • 1. Potential antileprotic agents. 1. Inhibition of a model mycobacterial system by diaryl sulfones.
    Colwell WT; Chan G; Brown VH; DeGraw JI; Peters JH; Morrison NE
    J Med Chem; 1974 Jan; 17(1):142-4. PubMed ID: 4585972
    [No Abstract]   [Full Text] [Related]  

  • 2. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 3. [Observation of antileprotic drug resistance].
    Ishihara S; Hagiwara S; Fukuda T
    Nihon Rai Gakkai Zasshi; 1984; 53(4):200-4. PubMed ID: 6399285
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug resistance of Mycobacterium leprae, particularly to DDS.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.
    Holmes IB; Hilson GR
    J Med Microbiol; 1972 May; 5(2):251-61. PubMed ID: 4555734
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report.
    Almeida JG; Christian M; Chacko CJ; Taylor PM; Fritschi EP
    Lepr Rev; 1983 Sep; 54(3):185-91. PubMed ID: 6355722
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug resistance in leprosy.
    Browne SG
    Lepr Rev; 1974 Sep; 45(3):276-8. PubMed ID: 4612275
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in the study of the leprosy bacillus.
    Rees RJ
    Sci Basis Med Annu Rev; 1969; ():320-35. PubMed ID: 4917843
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone.
    Seydel JK; Wempe EG; Rosenfeld M; Jagannathan R; Mahadevan PR; Dhople AM
    Arzneimittelforschung; 1990 Jan; 40(1):69-75. PubMed ID: 2187440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of repository sulfones against Mycobacterium leprae in mice.
    Shepard CC
    Proc Soc Exp Biol Med; 1967 Feb; 124(2):430-3. PubMed ID: 5335647
    [No Abstract]   [Full Text] [Related]  

  • 12. Dapsone-resistant leprosy in Ethiopia.
    Pearson JM; Haile GS; Barnetson RS; Rees RJ
    Lepr Rev; 1979 Sep; 50(3):183-99. PubMed ID: 392212
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycobacterium leprae persisters after treatment with dapsone and rifampicin.
    Pattyn SR; Dockx P; Rollier MT; Rollier R; Saerens EJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):154-8. PubMed ID: 776851
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of secondary dapsone-resistant leprosy in Upper Volta.
    Pattyn SR; Yada A; Sansarricq H; van Loo L
    Lepr Rev; 1984 Dec; 55(4):361-7. PubMed ID: 6396476
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid test for drug resistance in leprosy.
    Ambrose EJ; Khanolkar SR; Antia NH; Chulawalla RG; Koticha KK
    Lancet; 1977 Nov; 2(8046):1036. PubMed ID: 72940
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
    Waters MF; Pearson JM; Rees RJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
    [No Abstract]   [Full Text] [Related]  

  • 17. Dapsone-resistant leprosy and its implications for leprosy control programmes.
    Pearson JM; Cap JA; Haile GS; Rees RJ
    Lepr Rev; 1977 Jun; 48(2):83-94. PubMed ID: 331000
    [No Abstract]   [Full Text] [Related]  

  • 18. The problem of dapsone-resistant leprosy.
    Pearson JM
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):417-20. PubMed ID: 7042605
    [No Abstract]   [Full Text] [Related]  

  • 19. Dapsone-resistant leprosy-the THELEP approach.
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):421-5. PubMed ID: 7042606
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of sulphone resistance in leprosy patients in India.
    Taylor PM; Chacko CJ; Job CK
    Lepr Rev; 1976 Mar; 47(1):5-11. PubMed ID: 772342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.